Berenberg: Swiss Re likely facing $400mn in additional non-life Q4 Covid-19 claims
Swiss Re will likely incur additional Covid-19 losses of around $400mn in its P&C and Corporate Solutions businesses during the fourth quarter of 2020, according to Berenberg analysts.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below